Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
25.24
-0.30 (-1.17%)
At close: Sep 18, 2026, 4:00 PM EDT
25.24
0.00 (-0.01%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Arcus Biosciences Market Cap
Arcus Biosciences has a market cap or net worth of $3.21 billion as of September 18, 2026. Its market cap has increased by 151.01% in one year.
Market Cap
3.21B
Enterprise Value
2.68B
1-Year Change
151.01%
Ranking
Category
Stock Price
$25.24
ChartMarket Cap Chart
Since March 15, 2018, Arcus Biosciences's market cap has increased from $708.10M to $3.21B, an increase of 353.88%. That is a compound annual growth rate of 19.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 3.21B | 24.91% |
| Dec 31, 2025 | 2.57B | 88.83% |
| Dec 31, 2024 | 1.36B | -4.69% |
| Dec 29, 2023 | 1.43B | -4.52% |
| Dec 30, 2022 | 1.50B | -47.33% |
| Dec 31, 2021 | 2.84B | 68.68% |
| Dec 31, 2020 | 1.69B | 263.86% |
| Dec 31, 2019 | 463.20M | -3.26% |
| Dec 31, 2018 | 478.80M | -32.38% |
| Mar 15, 2018 | 708.10M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Enliven Therapeutics | 3.60B |
| Viking Therapeutics | 3.44B |
| Tarsus Pharmaceuticals | 3.41B |
| Legend Biotech | 3.29B |
| Arcutis Biotherapeutics | 3.29B |
| Dyne Therapeutics | 3.23B |
| Denali Therapeutics | 3.21B |
| Celldex Therapeutics | 3.04B |